Loading...
Loading...

2 mins read
The link between stress and depression is often thought of in subjective terms: emotional overload, adverse experiences, psychological strain. However, recent research suggests that chronic stress is not only experienced as a feeling, but can also consolidate into a sustained biological process, capable of persistently modifying the relationship between the immune system and the brain.
A study published in Nature Communications, based on experimental animal models, shows that prolonged exposure to stress activates the release of neutrophils, rapid-response immune cells, from the skull bone marrow into the meninges, the layers that surround and protect the brain. This displacement does not occur immediately or transiently: only after sustained exposure is a significant accumulation of these cells observed in the brain environment.
Unlike other components of the immune system, neutrophils that lodge in the meninges appear to retain characteristics of the cranial bone marrow. This suggests the existence of a direct communication circuit between this immune reservoir and the brain, independent of the bloodstream. Their prolonged presence in the meninges is associated with behavioral changes in animals, consistent with anxiety states and reduced interest in normally rewarding stimuli.
Genetic activity analysis of these cells reveals a particularly relevant feature: marked activation of type I interferon signaling, an immune pathway known to induce inflammatory processes and whose depressive side effects have already been observed in clinical contexts. This activation appears selectively in meningeal neutrophils, not in other cell types, pointing to a specific mechanism rather than a generalized inflammatory response.
When this signaling is experimentally blocked, neutrophil accumulation in the meninges decreases and stress-induced behavioral changes are attenuated. This suggests that part of the effects of chronic stress on mood do not originate directly in neurons, but in immune processes occurring in the brain’s immediate periphery.
The authors emphasize that a significant proportion of people with depression do not respond to traditional antidepressant treatments, raising the possibility that in some cases the disorder’s origin may be more related to inflammatory processes than to purely neurochemical alterations. In this context, identifying immune markers such as meningeal neutrophil activation could allow differentiation of patient subgroups and guide more specific therapeutic strategies.
Although the results come from animal models and have limitations (including the exclusive use of males), the study provides a coherent biological framework for understanding why sustained stress can translate into persistent mood symptoms. Far from reducing depression to an individual failure, these findings reinforce the idea that it is a complex biological phenomenon in which the immune system plays a central role in linking adversity and mental health.